Nanotechnology Finds Remedy in Nanocapsule for Heart Attack and Stroke
Australian scientists have incorporated nanotechnology in making small nanocapsules that would bring an immediate effect on the patients suffering from a heart attack or stroke
oslo,norway, August 6, 2015 (Newswire.com) - National Heart Foundation of Australia became the backbone of research and development, providing funds to the Australian scientists who are on their way to develop a nanocapsule that will be more effective in treating heart attack and stroke.
The research is ongoing under joint supervision of Professor Christoph Hagemeyer, Head of the Vascular Biotechnology Laboratory at Baker IDI Heart and Diabetes Institute and Professor Frank Caruso, an ARC Australian Laureate Fellow in the Department of Chemical and Biomolecular Engineering at the University of Melbourne.
Professor Christoph Hagemeyer said that the revolutionary idea of nanocapsule can help paramedics to act faster in emergency situations when lifesaving equipment are not available. The treatment will make a huge difference in the fields of medical treatment.
"This can be given in the ambulance straight away so you really save a lot of time and restore the blood flow to the critical organs much faster than currently possible," he said.
The heart attack is a very serious issue almost everywhere, millions of people suffer from this illness, and if immediate attention is not given to patient the chances of death increases.
The drug delivered to the patient is safer and more secure than the traditional medicine which have many side effects. And about a half portion of people do not take the risk of taking the current available treatment option as it might lead to serious bleeding.
“We’ve created a nanocapsule that contains a clot-busting drug,” he says. “The drug loaded nanocapsule is coated with an antibody that specifically targets activated platelets, the cells that form blood clots.”
The drugs that are administered act very fast as they are flowing freely in the blood stream it may be a potential harm to other clots. With the help of nanocapsules the accurate target will be reached where the clot is gathering base and blocking the blood flow in vessels. Thus, in a way other areas are not affected by the drug.
The research has been going on for over years now, and there’s still some time to implement nanotechnology applications for treating human illness.